SFT2D3 Antikörper (N-Term)
Kurzübersicht für SFT2D3 Antikörper (N-Term) (ABIN926563)
Target
Alle SFT2D3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- SFT2 D3 antibody was raised in rabbit using the N terminal of SFT2 3 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
SFT2D3 Blocking Peptide, (ABIN938209), is also available for use as a blocking control in assays to test for specificity of this SFT2D3 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- SFT2D3 (SFT2 Domain Containing 3 (SFT2D3))
-
Andere Bezeichnung
- SFT2D3
-
Hintergrund
- SFT2D3 may be involved in fusion of retrograde transport vesicles derived from an endocytic compartment with the Golgi complex. Synonyms: Polyclonal SFT2D3 antibody, Anti-SFT2D3 antibody, SFT2 domain containing 3 antibody, MGC5391 antibody.
Target
-